Page last updated: 2024-09-05

serratamolide and Breast Cancer

serratamolide has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giralt, E; Martinell, M; Montaner, B; Pérez-Tomás, R; Soto-Cerrato, V; Vilaseca, M	1

Other Studies

1 other study(ies) available for serratamolide and Breast Cancer

Article	Year
Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cells. Biochemical pharmacology, 2005, Dec-19, Volume: 71, Issue:1-2 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Depsipeptides; Enzyme Activation; Humans; Intracellular Membranes; Mitochondria; Tumor Suppressor Protein p53	2005

Article

Year

Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cells.

Biochemical pharmacology, 2005, Dec-19, Volume: 71, Issue:1-2

Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Depsipeptides; Enzyme Activation; Humans; Intracellular Membranes; Mitochondria; Tumor Suppressor Protein p53

2005